Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Prostatic Neoplasms 7Leiomyoma 6Menorrhagia 4Myofibroma 1Hormone Treatment-naïve Participants With Prostate Cancer 1Endometriosis 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7Norethindrone Acetate 5relugolix 4vilaprisan 2Uterine Artery Embolization 1Tranexamic Acid 1Progesterone 1Ibuprofen 1Cryosurgery 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Menorrhagia × relugolix × Clear all
NCT03751124 2024-06-25

Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Myovant Sciences GmbH

Phase 3 Completed
229 enrolled 66 charts

Leiomyoma, Menorrhagia, Myofibroma

NCT03412890 2024-05-09

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Myovant Sciences GmbH

Phase 3 Completed
477 enrolled 27 charts

Leiomyoma, Menorrhagia

NCT03103087 2022-04-20

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Myovant Sciences GmbH

Phase 3 Completed
382 enrolled 57 charts

Leiomyoma, Menorrhagia

NCT03049735 2022-04-19

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Myovant Sciences GmbH

Phase 3 Completed
388 enrolled 54 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡